Skip to main content

Table 2 The characteristics of patients with Kawasaki disease according to development of CADs

From: A decision tree model for predicting intravenous immunoglobulin resistance and coronary artery involvement in Kawasaki disease

  CADs (-) N = 740 CADs ( +) N = 156 P value
Age, months 31.86 ± 22.54 32.92 ± 26.15 0.60
Sex    0.53
 Male, n (%) 418 (56.4%) 93 (59.6%)  
 Female, n (%) 322 (43.5%) 63 (40.3%)  
WBC, 103/L 14.73 ± 4.75 15.22 ± 5.10 0.25
ANC, 103/L 9.59 ± 4.44 10.71 ± 4.87  < 0.01
Hematocrit, % 34.40 ± 13.06 34.33 ± 5.08 0.94
Platelet, 103/L 358.78 ± 101.58 346.15 ± 103.82 0.16
AST, U/L 83.23 ± 144.13 103.38 ± 169.70 0.12
ALT, U/L 81.05 ± 130.57 129.67 ± 169.03  < 0.01*
Albumin, g/dL 3.97 ± 0.95 3.82 ± 0.44 0.04
Total bilirubin, mg/dL 0.64 ± 0.82 1.04 ± 1.14  < 0.01*
CRP, mg/dL 7.94 ± 5.68 9.77 ± 6.85  < 0.01*
Na, mmol/L 136.37 ± 2.71 135.67 ± 3.01  < 0.01*
NT-proBNP, pg/mL 1192.48 ± 2049.08 2268.57 ± 4136.75  < 0.01*
IVIG resistance, n (%) 72 (9.7%) 39 (25.0%)  < 0.01*
  1. mean ± standard deviation or number (%). *means statistically significant; p values < 0.05
  2. IVIG Intravenous immunoglobulin, WBC White blood cells, ANC Absolute neutrophil counts, AST Aspartate aminotransferase, ALT Alanine transaminase, CRP C-reactive protein, NT-proBNP Nitrogen terminal- pro brain natriuretic peptide, CAD Coronary artery dilatation